Allspring Global Investments’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-259
Closed -$14.2K 2875
2023
Q2
$14.2K Buy
259
+58
+29% +$3.69K ﹤0.01% 2506
2023
Q1
$13.7K Buy
201
+148
+279% +$11.5K ﹤0.01% 2559
2022
Q4
$3.24K Sell
53
-2
-4% -$186 ﹤0.01% 2819
2022
Q3
$5K Buy
+55
New +$6.41K ﹤0.01% 2782

Other funds holding RBOT

Allspring Global Investments's RBOT Position: Q3 2023 in Review

Allspring Global Investments sold out of Vicarious Surgical (RBOT) in Q3 2023, closing a stake of 259 shares — an estimated $14.2K sold.

Allspring Global Investments first reported a position in RBOT in Q3 2022 and held it in 4 quarters. The position peaked at $14.2K in Q2 2023. 83 funds tracked by Wall St. Rank hold RBOT as of Q3 2023.

  • Allspring Global Investments reported no remaining Vicarious Surgical position as of Q3 2023 after selling out during the quarter.
  • Allspring Global Investments sold 259 Vicarious Surgical shares in Q3 2023, an estimated $14.2K.
  • Allspring Global Investments first reported a position in Vicarious Surgical in Q3 2022 and held it in 4 quarters.
  • Allspring Global Investments's Vicarious Surgical position peaked at $14.2K in Q2 2023.
  • 83 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2023.

Based on Allspring Global Investments's 13F filing for Q3 2023, filed 27 Oct 2023.